BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33308220)

  • 1. Induction chemotherapy for the individualised treatment of hypopharyngeal carcinoma with cervical oesophageal invasion: a retrospective cohort study.
    Huang TQ; Wang R; Fang JG; He SZ; Zhong Q; Hou LZ; Ma HZ; Chen XH; Chen XJ; Li PD; Feng L; Shi Q; Lian M
    World J Surg Oncol; 2020 Dec; 18(1):330. PubMed ID: 33308220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative analysis of clinical efficacies between induction chemotherapy and surgery combined with radiotherapy or concurrent chemoradiotherapy in advanced hypopharyngeal carcinoma].
    Li ZD; Lu T
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Dec; 53(12):918-924. PubMed ID: 30585004
    [No Abstract]   [Full Text] [Related]  

  • 3. [A single-arm prospective study on induction chemotherapy and subsequent comprehensive therapy for advanced hypopharyngeal squamous cell carcinoma: report of 260 cases in a single center].
    Yang YF; Wang R; Fang JG; Zhong Q; Huang ZG; Chen XH; Zhang SR; Gao JM; Li SL; Li PD; Hou LZ; Chen XJ; Ma HZ; Feng L; Zhang Y; He SZ; Lian M; Liu SZ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Dec; 55(12):1143-1153. PubMed ID: 33342130
    [No Abstract]   [Full Text] [Related]  

  • 4. Induction chemotherapy followed by cisplatin or cetuximab concomitant to radiotherapy for laryngeal/hypopharyngeal cancer: Long-term results of the TREMPLIN randomised GORTEC trial.
    Janoray G; Pointreau Y; Alfonsi M; Sire C; Geoffrois L; de Raucourt D; Bardet E; Calais MH; Garaud P; Calais G
    Eur J Cancer; 2020 Jul; 133():86-93. PubMed ID: 32454417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of combined radiotherapy with EGFR inhibitors and chemotherapy for laryngeal organ preservation in patients with locally advanced hypopharyngeal carcinomas.
    Zhang X; Wang J; Wu W; Liu M; Zhao F; Du L; Huang D; Yang S; Ma L
    Curr Cancer Drug Targets; 2014; 14(6):589-98. PubMed ID: 25039274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoradiotherapy laryngeal preservation for advanced hypopharyngeal cancer.
    Tai SK; Yang MH; Wang LW; Tsai TL; Chu PY; Wang YF; Huang JL; Chang SY
    Jpn J Clin Oncol; 2008 Aug; 38(8):521-7. PubMed ID: 18697758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changing trend in prognosis of primary hypopharyngeal carcinoma and reason analysis: date comparison of 2003-2007 and 2010-2014 in a single centre].
    Tao L; Zhou L; Zhang M; Wu HT; Li XM; Chen XL; Li C; Xie M; Cheng L; Heng Y
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Feb; 55(2):116-124. PubMed ID: 32074749
    [No Abstract]   [Full Text] [Related]  

  • 8. [Non-surgical combined modality treatments for laryngeal organ preservation in advanced hypopharyngeal carcinoma].
    Zhang X; Wang J; Wu W; Ma L; Liu M; Zhao F; Huang D
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jul; 49(7):558-63. PubMed ID: 25257270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective analysis of the clinical efficacy of definitive chemoradiotherapy for patients with hypopharyngeal cancer.
    Takehana K; Kodaira T; Tachibana H; Kimura K; Shimizu A; Makita C; Tomita N; Nishikawa D; Suzuki H; Hirakawa H; Hanai N; Hasegawa Y
    Jpn J Clin Oncol; 2016 Apr; 46(4):344-9. PubMed ID: 26826721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment and prognosis of 264 patients with hypopharyngeal carcinoma].
    Xu W; Lyu ZH; Sa N; Ma JK; Tian JJ; Feng SH; Cui P; Cao HY
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 53(5):346-351. PubMed ID: 29764015
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of induction chemotherapy followed by surgery in unresectable stage IVb laryngeal and hypopharyngeal cancers: a case series.
    Sittitrai P; Reunmarkkaew D; Chaiyasate S
    J Otolaryngol Head Neck Surg; 2018 Oct; 47(1):62. PubMed ID: 30326958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cycle induction chemotherapy for resectable advanced hypopharyngeal cancer.
    Nakashima T; Yasumatsu R; Asai K; Uryu H; Kogo R; Nakagawa T
    Int J Clin Oncol; 2017 Jun; 22(3):442-447. PubMed ID: 28062933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different clinical outcomes between locally advanced hypopharyngeal and oropharyngeal cancer treated with definitive concurrent chemoradiotherapy: implication for subgroup selection for induction chemotherapy.
    Lim SH; Lee SJ; Ahn MJ; Park K; Sun JM
    Jpn J Clin Oncol; 2016 Jan; 46(1):40-5. PubMed ID: 26561556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness of chemoradiation therapy and salvage surgery for hypopharyngeal squamous cell carcinoma.
    Suzuki K; Hayashi R; Ebihara M; Miyazaki M; Shinozaki T; Daiko H; Sakuraba M; Zenda S; Tahara M; Fujii S
    Jpn J Clin Oncol; 2013 Dec; 43(12):1210-7. PubMed ID: 24031082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definitive Radiotherapy Following Induction Chemotherapy for Hypopharyngeal Cancer: Selecting Candidates for Organ-Preserving Treatment Based on the Response to Induction Chemotherapy.
    Yanagi T; Shibamoto Y; Ogino H; Baba F; Murai T; Nagai A; Miyakawa A; Sugie C
    Kurume Med J; 2016; 62(1-2):1-8. PubMed ID: 26935442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The clinical characteristics and two different treatment outcomes of 321 patients with hypopharyngeal squamous cell carcinoma].
    Lu T; Li ZD; Li SC; Li YG; Liu HW; Jiang L; Huang DN; Wei HM; Liu Z
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Mar; 33(3):275-279. PubMed ID: 30813702
    [No Abstract]   [Full Text] [Related]  

  • 17. Concurrent chemoradiotherapy for organ function preservation in advanced patients with hypopharyngeal and laryngeal cancer.
    Kogashiwa Y; Yamauchi K; Nagafuji H; Matsuda T; Tsubosaka T; Tsutsumi T; Karaho T; Kohno N
    Oncol Rep; 2009 Nov; 22(5):1163-7. PubMed ID: 19787235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of different laryngeal preservation strategies based on chemoradiotherapy in locally advanced hypopharyngeal carcinoma].
    Luo X; Sun S; Xu Y; Huang X; Wang K; Wu R; Wang J; Zhang Y; Zhang J; Chen X; Qu Y; Luo J; Yi J
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Sep; 37(9):708-714. PubMed ID: 37640994
    [No Abstract]   [Full Text] [Related]  

  • 19. [A retrospective study on combined modality therapy with or without surgery for advanced hypopharyngeal squamous cell carcinoma: an analysis of 119 cases].
    Zhang YX; Peng HH; Zhang XX; Zhao JD; Wu WM; Wang JL; Huang DL; Zong L; Chen LW; Liu CQ; Liu MB
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 53(5):352-358. PubMed ID: 29764016
    [No Abstract]   [Full Text] [Related]  

  • 20. Induction chemotherapy plus IMRT alone versus induction chemotherapy plus IMRT-based concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study.
    Wei Z; Zhang Z; Luo J; Li N; Peng X
    J Cancer Res Clin Oncol; 2019 Jul; 145(7):1857-1864. PubMed ID: 31062162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.